DHCNI — Stock Film
STOCK FILMSCENE 1/11DHCNI · $18.49
Stock Expert AI presents
DHCNI
Diversified Healthcare Trust, 5.625% Senior Notes due 2042
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Diversified Healthcare Trust, 5.625% Senior Notes due 2042. A quick introduction.

On the stock market since 2012, it operates in the world of real estate. Now — the numbers.

on the stock market since 2012
$2.1B market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $1.2.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

WHERE DOES THE MONEY COME FROM?
85%Resident Fees and Services
Resident Fees and Services 85%Rental Income 15%
85% of all revenue comes from a single line: Resident Fees and Services.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

THE SALES TREND
Sales are moving sideways.

No real growth (3% a year). Red columns mark years that ended in a loss.

$1.4B
2021
$1.3B
2022
$1.4B
2023
$1.5B
2024
$1.5B
2025
In the vault right now:
$0
DEBT: $2.4B
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
7
very weak

Clearly below the class average.

FINANCIAL STRENGTH
40
weak

Clearly below the class average.

VALUATION
25
very weak

Clearly below the class average.

GROWTH
10
very weak

Clearly below the class average.

PRICE MOMENTUM
61
average

The price is looking for direction — no strong breakout, no collapse.

WORTH WATCHING

Business Quality: Profit power and business quality trail similar companies in the sector.

Growth: Sales growth trails the sector average.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 26% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/2
Sales are holding up

The company sells $1.5B a year; the problem isn’t sales — it’s costs running above that number.

2
THE BRIGHT SIDE · 2/2
Pays a steady dividend

It pays out $1.41 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/2
The losses continue

A loss of $285.9M against $1.5B in annual sales.

2
THE RISKS · 2/2
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
F
0 / 100 · MoonshotScore

On our five-subject report card, DHCNI sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: DHCNI has solid sales but closed last year at a loss. The road back to profit runs through spending discipline.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film